(3S)-1-[3-(3-chloro-5-fluorophenyl)-5-(4-fluoro-1H-benzimidazol-2-yl)-4-pyridinyl]pyrrolidin-3-amine
C22H18ClF2N5 — CID 139392711
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-1-[3-(3-chloro-5-fluorophenyl)-5-(4-fluoro-1H-benzimidazol-2-yl)-4-pyridinyl]pyrrolidin-3-amine
(3S)-1-[3-(3-chloro-5-fluorophenyl)-5-(4-fluoro-1H-benzimidazol-2-yl)-4-pyridinyl]pyrrolidin-3-amine (PubChem CID 139392711) has the molecular formula C22H18ClF2N5 and a molecular weight of 425.87 g/mol. Its IUPAC name is (3S)-1-[3-(3-chloro-5-fluorophenyl)-5-(4-fluoro-1H-benzimidazol-2-yl)-4-pyridinyl]pyrrolidin-3-amine.
Molecular Properties
| Compound Name | (3S)-1-[3-(3-chloro-5-fluorophenyl)-5-(4-fluoro-1H-benzimidazol-2-yl)-4-pyridinyl]pyrrolidin-3-amine |
|---|---|
| PubChem CID | 139392711 |
| Molecular Formula | C22H18ClF2N5 |
| Molecular Weight | 425.87 g/mol |
| Exact Mass | 425.12 |
| IUPAC Name | (3S)-1-[3-(3-chloro-5-fluorophenyl)-5-(4-fluoro-1H-benzimidazol-2-yl)-4-pyridinyl]pyrrolidin-3-amine |
| SMILES | N[C@H]1CCN(c2c(-c3cc(F)cc(Cl)c3)cncc2-c2nc3c(F)cccc3[nH]2)C1 |
| InChI | InChI=1S/C22H18ClF2N5/c23-13-6-12(7-14(24)8-13)16-9-27-10-17(21(16)30-5-4-15(26)11-30)22-28-19-3-1-2-18(25)20(19)29-22/h1-3,6-10,15H,4-5,11,26H2,(H,28,29)/t15-/m0/s1 |
| InChIKey | KNURDJSPJNPJSP-HNNXBMFYSA-N |
| XLogP | 4.76 |
| TPSA | 70.83 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 425.87 |
| LogP ≤ 5 | 4.76 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139392711 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.